BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Metabolomics Society - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Metabolomics Society
X-ORIGINAL-URL:https://metabolomicssociety.org
X-WR-CALDESC:Events for Metabolomics Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210112
DTEND;VALUE=DATE:20210115
DTSTAMP:20260511T193319
CREATED:20231117T212644Z
LAST-MODIFIED:20231204T182401Z
UID:5845-1610409600-1610668799@metabolomicssociety.org
SUMMARY:Targeted Therapies and Companion Diagnostic Tests. From development to "market access" Targeted Therapies and Companion Diagnostic Tests. From Development to "Market Access".
DESCRIPTION:January 12 & 14\, 2021 \nOverview: \n\nUnderstand the definitions and regulatory framework governing these products. Impact of new European DM regulations and DMDIV.\nHow to proceed with the analytical validation.\nHow to demonstrate clinical validity and prove clinical utility.\nWhat development strategy to adopt?.\n\nAnd much more. Click here for more details.
URL:https://metabolomicssociety.org/event/targeted-therapies-and-companion-diagnostic-tests-from-development-to-market-access-targeted-therapies-and-companion-diagnostic-tests-from-development-to-market-access/
LOCATION:Webinar\, Webinar\, United States
END:VEVENT
END:VCALENDAR